CT与MRI LI-RADS v2014 1、2、3、4类观察的纵向演变
本回顾性研究纳入本机构2014年1月至2017年9月372个未治疗LI-RADS v2014 1–4类观察(214例患者,共715次检查),评估各类别进展风险及检查间 modality 或放射科医生变化对分类的影响。结果显示6个月进展为恶性类别的累积发生率LR-1为0%、LR-2为2%、LR-3为7%、LR-4为32%;MRI-MRI检查对较CT-CT分类更稳定(OR=0.460,p=0.0018)。
要点
- 6个月进展为恶性类别的累积发生率:LR-1 0%、LR-2 2%、LR-3 7%、LR-4 32%。
- MRI-MRI检查对的LI-RADS分类较CT-CT更稳定(OR=0.460,p=0.0018)。
- 放射科医生变化与LI-RADS分类变化无显著关联。
核心结论
- LI-RADS观察进展为恶性的风险随类别升高而增加,6个月时从LR-1的0%至LR-4的32%;检查间modality变化与LI-RADS分类变化相关。
研究设计与样本
- 回顾性识别本机构2014年1月至2017年9月临床LI-RADS v2014 CT和MRI检查,纳入至少一次随访的未治疗LR-1、LR-2、LR-3、LR-4观察,共372个观察(214例患者,149男、65女,平均年龄61±10岁),总计715次检查。
关键影像表现/征象
- LI-RADS观察的类别越高,进展为恶性类别的累积发生率越高。
- MRI-MRI检查对的LI-RADS分类较CT-CT更稳定(OR=0.460,p=0.0018)。
- 不同modality的连续检查间的类别变化可能反映modality差异而非生物学变化。
诊断标准与关键数值
- 进展为恶性类别(LR-5或LR-M)的6个月累积发生率:LR-1为0%、LR-2为2%、LR-3为7%、LR-4为32%,各指数类别间差异显著(p<0.0001)。
- 进展为LR-4或更高的累积发生率在LR-1、LR-2、LR-3间差异显著(p=0.003)。
- MRI-MRI检查对较CT-CT的LI-RADS分类稳定性OR=0.460(p=0.0018)。
临床应用与阅片要点
- 在临床实践环境中,放射科医生参考既往影像和报告时,放射科医生变化与LI-RADS分类变化无显著关联。
- 使用不同modality(CT vs MRI)的连续检查间的类别变化可能反映modality差异而非生物学变化。
- MRI,尤其是使用相同类型对比剂时,可能提供最可重复的分类,尽管这需要额外验证。
局限性
- 原文指出MRI可能提供最可重复的分类,但需要额外验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study assesses the risk of progression of Liver Imaging Reporting and Data System (LI-RADS) categories, and the effects of inter-exam changes in modality or radiologist on LI-RADS categorization.
METHODS: Clinical LI-RADS v2014 CT and MRI exams at our institution between January 2014 and September 2017 were retrospectively identified. Untreated LR-1, LR-2, LR-3, and LR-4 observations with at least one follow-up exam were included. Three hundred and seventy-two observations in 214 patients (149 male, 65 female, mean age 61 ± 10 years) were included during the study period (715 exams total). Cumulative incidence curves for progression to malignant LI-RADS categories (LR-5 or LR-M) and to LR-4 or higher were generated for each index category and compared using log-rank tests with a resampling extension. Relationships between inter-exam changes in LI-RADS category and modality or radiologist, adjusted for inter-exam time intervals, were modeled using mixed effect logistic regressions.
RESULTS: Median inter-exam follow-up interval and total follow-up duration were 123 and 227 days, respectively. Index LR-1, LR-2, LR-3, and LR-4 differed significantly in their cumulative incidences of progression to malignant categories (p < 0.0001), which were 0%, 2%, 7%, and 32% at 6 months, respectively. Index LR-1, LR-2, and LR-3 differed significantly in cumulative incidences of progression to LR-4 or higher (p = 0.003). MRI-MRI exam pairs had more stable LI-RADS categorization compared to CT-CT (OR = 0.460, p = 0.0018).
CONCLUSIONS: LI-RADS observations demonstrate increasing risk of progression to malignancy with increasing category ranging from 0% for LR-1 to 32% for LR-4 at 6 months. Inter-exam modality changes are associated with LI-RADS category changes.
KEY POINTS: • While the majority of LR-2 observations remain stable over long-term follow-up, LR-3 and especially LR-4 observations have a higher risk for category progression. • Category transitions between sequential exams using different modalities (CT vs. MRI) may reflect modality differences rather than biological change. MRI, especially with the same type of contrast agent, may provide the most reproducible categorization, although this needs additional validation. • In a clinical practice setting, in which radiologists refer to prior imaging and reports, there was no significant association between changes in radiologist and changes in LI-RADS categorization.
引用
- Hong CW, Park CC, Mamidipalli A, et al. Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations. Eur Radiol. 2019. PMID: 30809719. doi:10.1007/s00330-019-06058-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。